Clinical Trials
4 trialsNCT00290251 2024-07-15
Treatment of Uterine Fibroids With the Selective Progesterone Receptor Modulator CDB-2914
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT00044876 2019-12-17
Treatment of Uterine Fibroids With CDB-2914, an Experimental Selective Progesterone Receptor Antagonist
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT00332033 2017-07-02
Development of a Non-Invasive Treatment for Uterine Leiomyoma (Fibroids)
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT00087841 2008-01-17
Self-Hypnotic Relaxation Therapy During Invasive Procedures
National Center for Complementary and Integrative Health (NCCIH)
Phase 2 Completed